![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 14/755 | |
A61K 38/37 |
(11) | Number of the document | 2536753 |
(13) | Kind of document | T |
(96) | European patent application number | 11701527.1 |
Date of filing the European patent application | 2011-02-02 | |
(97) | Date of publication of the European application | 2012-12-26 |
(45) | Date of publication and mention of the grant of the patent | 2017-12-20 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2011/051438 |
Date | 2011-02-02 |
(87) | Number | WO 2011/101242 |
Date | 2011-08-25 |
(30) | Number | Date | Country code |
305608 P | 2010-02-18 | US | |
10153718 | 2010-02-16 | EP |
(72) |
PESCHKE, Bernd, DK
KOFOD-HANSEN, Mikael, DK
BUCHARDT, Jens, DK
STENNICKE, Henning Ralf, DK
STERGAARD, Henrik, DK
KJALKE, Marianne, DK
OLSEN, Eva H. Norling, DK
HANSEN, Jens Jacob, DK
|
(73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
(54) | FACTOR VIII MOLECULES WITH REDUCED VWF BINDING |
FACTOR VIII MOLECULES WITH REDUCED VWF BINDING |